Navigation Links
Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock
Date:6/22/2009

Leader in consumer probiotics expands into livestock industry with Direct Fed Microbial offering.

MAYFIELD HEIGHTS, Ohio, June 22 /PRNewswire/ -- Ganeden Biotech, Inc., the largest seller of over-the-counter probiotics in the U.S., today announced the launch of GanPro(TM), an all-natural animal feed additive containing a direct-fed microbial (DFM) that has been shown to support gut health and naturally promote feed conversion in livestock.

Enhanced with one of Ganeden Biotech's patented strains of Bacillus coagulans, GanPro survives pelleting and other manufacturing processes as well as the harsh stomach environment of the animal. GanPro delivers consistent results, is cost-effective and is easier to use than many other DFM and lactic acid bacteria (LAB) products because, unlike many DFM and LAB products, it can be mixed directly with animal feed, does not need to be administered separately and does not require refrigeration. GanPro is appropriate for livestock of all ages. Recommended feeding rates per head are: 36 grams per day for cattle; 5.5 grams per day for pigs; and 1 gram per day for chickens. The product, which is sold directly by Ganeden Biotech, is available in bulk quantities and 50-pound bags.

The bacterial strain in GanPro has been shown to:

  • improve feed conversion ratios by increasing daily weight gain
  • increase immune system response
  • maintain the balance between good and bad gut bacteria

"Ganeden Biotech is proud to introduce GanPro as a cost-effective solution for livestock farmers who are looking for safe ways to improve feed conversion ratios and naturally improve livestock health," said Devon Durkee, Ph.D., technical account manager at Ganeden Biotech. "Because the probiotic strain used in GanPro is highly viable and able to survive in an animal's digestive tract, it is a great alternative to more traditional DFMs."

Probiotics, known as direct-fed microbials, or DFMs, in the animal nutrition industry, are good bacteria that have been shown to improve both digestive and immune health in animals. The protective nature of the Bacillus coagulans strain used in GanPro allows the bacteria to survive harsh manufacturing processes and the stomach environments of the animals to reach their digestive tract where they can grow creating the maximum benefit to the animal.

"We're excited to enter the farming and livestock production industry with GanPro," said Andy Lefkowitz, Ganeden Biotech's CEO. "This innovative product provides farmers and ranchers with a natural and effective way to improve livestock health and positively influence feed conversion without the use of antibiotics."

About Ganeden Biotech, Inc.

Established in 2006, Ganeden Labs is the licensing and development division of Ganeden Biotech, the largest seller of over-the-counter probiotic bacteria in the United States. Ganeden Labs makes proprietary, patented probiotic technology available for use in innovative products in a wide range of industries. Ganeden Labs also maintains an extensive intellectual property portfolio with patent and trademark protection for an array of technologies all over the world. Ganeden Biotech's various strains of Bacillus coagulans and its related patents are available for license in functional foods and beverages, supplements, animal health products and topical applications.


'/>"/>
SOURCE Ganeden Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
2. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
3. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
4. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
5. Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener
6. Ganeden Biotech, Liquid Health Labs Unveil New Drink Technology
7. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
10. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
11. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... ... ... NDA Partners Chairman Carl Peck, MD , announced today that Richard Kenley, ... Pharmaceutical Development Business Unit of Cardinal Health, has joined the firm as an Expert ... Chief Operating Officer at Anaborex, Senior VP and General Manager of the San Diego ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... compliance and commercialization, has just released version 9.0 of the Cognition Cockpit platform. ... version of Cockpit,” says David Cronin, CEO of Cognition. “We’re thrilled to finally ...
(Date:5/18/2017)... ... May 17, 2017 , ... HOLLOWAY ... industries, including food and dairy, munitions, and pharmaceutical/biotech, recently introduced The Revolution Lift™, ... of use. The improvement in technology comes on the heels of HOLLOWAY’s release ...
(Date:5/18/2017)... ... May 17, 2017 , ... Many ... more likely to develop Alzheimer’s disease, while men are at greater risk for ... gender-specific neuronal bias is the aim of a research program at Worcester Polytechnic ...
Breaking Biology Technology:
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
Breaking Biology News(10 mins):